Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efaproxiral and Carmustine in Recurrent Malignant Glioma
NCT00005855Phase 2Completed
- Sponsor
- New Approaches to Brain Tumor Therapy Consortium
- Start
- Jul 2000
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of efaproxiral in malignant glioma, sponsored by New Approaches to Brain Tumor Therapy Consortium. Started Jul 2000; status: completed.
02
Drugs
efaproxiral
03
Conditions
malignant glioma
Beyond the preview
Go deeper on NCT00005855.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00005855.